Your browser doesn't support javascript.
loading
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.
Mitchell, Jonathan S; Li, Ni; Weinhold, Niels; Försti, Asta; Ali, Mina; van Duin, Mark; Thorleifsson, Gudmar; Johnson, David C; Chen, Bowang; Halvarsson, Britt-Marie; Gudbjartsson, Daniel F; Kuiper, Rowan; Stephens, Owen W; Bertsch, Uta; Broderick, Peter; Campo, Chiara; Einsele, Hermann; Gregory, Walter A; Gullberg, Urban; Henrion, Marc; Hillengass, Jens; Hoffmann, Per; Jackson, Graham H; Johnsson, Ellinor; Jöud, Magnus; Kristinsson, Sigurður Y; Lenhoff, Stig; Lenive, Oleg; Mellqvist, Ulf-Henrik; Migliorini, Gabriele; Nahi, Hareth; Nelander, Sven; Nickel, Jolanta; Nöthen, Markus M; Rafnar, Thorunn; Ross, Fiona M; da Silva Filho, Miguel Inacio; Swaminathan, Bhairavi; Thomsen, Hauke; Turesson, Ingemar; Vangsted, Annette; Vogel, Ulla; Waage, Anders; Walker, Brian A; Wihlborg, Anna-Karin; Broyl, Annemiek; Davies, Faith E; Thorsteinsdottir, Unnur; Langer, Christian; Hansson, Markus.
Afiliação
  • Mitchell JS; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Li N; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Weinhold N; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
  • Försti A; Department of Internal Medicine V, University of Heidelberg, 69117 Heidelberg, Germany.
  • Ali M; German Cancer Research Center, 69120 Heidelberg, Germany.
  • van Duin M; Center for Primary Health Care Research, Lund University, SE-205 02 Malmo, Sweden.
  • Thorleifsson G; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Johnson DC; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA Rotterdam, The Netherlands.
  • Chen B; deCODE Genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
  • Halvarsson BM; Division of Molecular Pathology, The Institute of Cancer Research, Surrey SM2 5NG, UK.
  • Gudbjartsson DF; German Cancer Research Center, 69120 Heidelberg, Germany.
  • Kuiper R; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Stephens OW; deCODE Genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
  • Bertsch U; School of Engineering and Natural Sciences, University of Iceland, IS-101 Reykjavik, Iceland.
  • Broderick P; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA Rotterdam, The Netherlands.
  • Campo C; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
  • Einsele H; Department of Internal Medicine V, University of Heidelberg, 69117 Heidelberg, Germany.
  • Gregory WA; National Centre of Tumor Diseases, 69120 Heidelberg, Germany.
  • Gullberg U; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Henrion M; German Cancer Research Center, 69120 Heidelberg, Germany.
  • Hillengass J; University Clinic of Würzburg, 97080 Würzburg, Germany.
  • Hoffmann P; Clinical Trials Research Unit, University of Leeds, Leeds LS2 9PH, UK.
  • Jackson GH; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Johnsson E; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Jöud M; Department of Internal Medicine V, University of Heidelberg, 69117 Heidelberg, Germany.
  • Kristinsson SY; Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany.
  • Lenhoff S; Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Lenive O; Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
  • Mellqvist UH; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Migliorini G; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Nahi H; Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, SE-221 85 Lund, Sweden.
  • Nelander S; Department of Hematology, Landspitali, National University Hospital of Iceland, IS-101 Reykjavik, Iceland.
  • Nickel J; Hematology Clinic, Skåne University Hospital, SE-221 85 Lund, Sweden.
  • Nöthen MM; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Rafnar T; Section of Hematology, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden.
  • Ross FM; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • da Silva Filho MI; Center for Hematology and Regenerative Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Swaminathan B; Rudbeck Laboratory, Department of Immunology, Pathology and Genetics, Uppsala University, SE-751 05 Uppsala, Sweden.
  • Thomsen H; Department of Internal Medicine V, University of Heidelberg, 69117 Heidelberg, Germany.
  • Turesson I; Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany.
  • Vangsted A; Department of Genomics, Life &Brain Center, University of Bonn, D-53127 Bonn, Germany.
  • Vogel U; deCODE Genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
  • Waage A; Wessex Regional Genetics Laboratory, University of Southampton, Salisbury SP2 8BJ, UK.
  • Walker BA; German Cancer Research Center, 69120 Heidelberg, Germany.
  • Wihlborg AK; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, SE-221 84 Lund, Sweden.
  • Broyl A; German Cancer Research Center, 69120 Heidelberg, Germany.
  • Davies FE; Hematology Clinic, Skåne University Hospital, SE-221 85 Lund, Sweden.
  • Thorsteinsdottir U; Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
  • Langer C; National Research Centre for the Working Environment, DK-2100 Copenhagen, Denmark.
  • Hansson M; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491 Trondheim, Norway.
Nat Commun ; 7: 12050, 2016 07 01.
Article em En | MEDLINE | ID: mdl-27363682

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido